Literature DB >> 21177806

The IFITM proteins inhibit HIV-1 infection.

Jennifer Lu1, Qinghua Pan, Liwei Rong, Wei He, Shan-Lu Liu, Chen Liang.   

Abstract

Type I interferon protects cells from virus infection through the induction of a group of genes collectively named interferon-stimulated genes (ISGs). In this study, we utilized short hairpin RNA (shRNA) to deplete ISGs in SupT1 cells in order to identify ISGs that suppress the production of human immunodeficiency virus type 1 (HIV-1). Among the ISG candidates thus identified were interferon-induced transmembrane (IFITM) proteins, including IFITM1, IFITM2, and IFITM3, that potently inhibit HIV-1 replication at least partially through interfering with virus entry. Further mutagenesis analysis shows that the intracellular region, rather than the N- and C-terminal extracellular domains, is essential for the antiviral activity of IFITM1. Altogether, these data suggest that the IFITM proteins serve as important components of the innate immune system to restrict HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21177806      PMCID: PMC3067758          DOI: 10.1128/JVI.01531-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  Effects of IFN alpha on late stages of HIV-1 replication cycle.

Authors:  F Dianzani; C Castilletti; M Gentile; H R Gelderblom; F Frezza; M R Capobianchi
Journal:  Biochimie       Date:  1998 Aug-Sep       Impact factor: 4.079

2.  Phase I trial of interferon alfa-n3 in early-stage human immunodeficiency virus type 1 disease: evidence for drug safety, tolerance, and antiviral activity.

Authors:  D R Skillman; J L Malone; C F Decker; K F Wagner; R L Mapou; M J Liao; D Testa; M S Meltzer
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

3.  Regulation of human immunodeficiency virus replication by 2',5'-oligoadenylate-dependent RNase L.

Authors:  R K Maitra; R H Silverman
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR.

Authors:  K Nagai; A H Wong; S Li; W N Tam; A R Cuddihy; N Sonenberg; M B Mathews; J Hiscott; M A Wainberg; A E Koromilas
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Use of recombinant interferon-alpha in human immunodeficiency virus (HIV)-infected individuals.

Authors:  J Rivero; M Limonta; A Aguilera; M Fraga; P López Saura
Journal:  Biotherapy       Date:  1994

6.  Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.

Authors:  M J Korth; M D Taylor; M G Katze
Journal:  Virology       Date:  1998-08-01       Impact factor: 3.616

7.  Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells.

Authors:  Brian P Doehle; Florian Hladik; John P McNevin; M Juliana McElrath; Michael Gale
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

8.  Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study Group.

Authors:  E Fernández-Cruz; J M Lang; J Frissen; V Furner; M Châteauvert; C A Boucher; P Dowd; J Stevens
Journal:  AIDS       Date:  1995-09       Impact factor: 4.177

9.  Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.

Authors:  M B Agy; R L Acker; C H Sherbert; M G Katze
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

10.  HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.

Authors:  Kosuke Miyauchi; Yuri Kim; Olga Latinovic; Vladimir Morozov; Gregory B Melikyan
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

View more
  223 in total

1.  S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus.

Authors:  Jacob S Yount; Roos A Karssemeijer; Howard C Hang
Journal:  J Biol Chem       Date:  2012-04-17       Impact factor: 5.157

2.  Δ20 IFITM2 differentially restricts X4 and R5 HIV-1.

Authors:  Wan-Lin Wu; Christopher Robert Grotefend; Ming-Ting Tsai; Yi-Ling Wang; Vladimir Radic; Hyungjin Eoh; I-Chueh Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

3.  CD56+ T cells inhibit HIV-1 infection of macrophages.

Authors:  Wei Hou; Li Ye; Wen-Zhe Ho
Journal:  J Leukoc Biol       Date:  2012-05-16       Impact factor: 4.962

4.  Interferon epsilon promotes HIV restriction at multiple steps of viral replication.

Authors:  Albert Garcia-Minambres; Sahar G Eid; Niamh E Mangan; Corinna Pade; San S Lim; Antony Y Matthews; Nicole A de Weerd; Paul J Hertzog; Johnson Mak
Journal:  Immunol Cell Biol       Date:  2017-01-03       Impact factor: 5.126

5.  Elevated viral restriction factor levels in cortical blood vessels in schizophrenia.

Authors:  Benjamin I Siegel; Elizabeth J Sengupta; Jessica R Edelson; David A Lewis; David W Volk
Journal:  Biol Psychiatry       Date:  2013-09-30       Impact factor: 13.382

Review 6.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

Review 7.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

8.  Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection.

Authors:  Haitao Hu; Martin Nau; Phil Ehrenberg; Agnes-Laurence Chenine; Camila Macedo; Yu Zhou; Z John Daye; Zhi Wei; Maryanne Vahey; Nelson L Michael; Jerome H Kim; Mary Marovich; Silvia Ratto-Kim
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

9.  TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium.

Authors:  Stephanie Bertram; Ronald Dijkman; Matthias Habjan; Adeline Heurich; Stefanie Gierer; Ilona Glowacka; Kathrin Welsch; Michael Winkler; Heike Schneider; Heike Hofmann-Winkler; Volker Thiel; Stefan Pöhlmann
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

10.  Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation.

Authors:  Bahar Kasaai; Marie-Hélène Gaumond; Pierre Moffatt
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.